Stockscreener 앱 받기
7.47
0.67%
0.05
시간 외 거래:
7.47
전일 마감가:
$7.42
열려 있는:
$7.38
하루 거래량:
388.87K
Relative Volume:
1.34
시가총액:
$267.80M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-5.32%
1개월 성능:
+33.16%
6개월 성능:
+78.28%
1년 성능:
-66.90%
1일 변동 폭
$7.2929
$7.68
1주일 범위
$7.09
$8.15
52주 변동 폭
$2.88
$23.72
Bioage Labs Inc Stock (BIOA) Company Profile
명칭
Bioage Labs Inc
전화
510-806-1445
주소
5885 HOLLIS STREET, EMERYVILLE
BIOA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
7.47 | 266.01M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.63B | 260.53M | 4.77B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-02-28 | 개시 | William Blair | Mkt Perform |
| 2024-12-10 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-09 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-10-21 | 개시 | Citigroup | Buy |
| 2024-10-21 | 개시 | Jefferies | Buy |
| 2024-10-21 | 개시 | Morgan Stanley | Overweight |
모두보기
Bioage Labs Inc 주식(BIOA)의 최신 뉴스
Is BioAge Labs Inc. stock attractive for long term wealth buildingCEO Change & Accurate Intraday Trade Tips - newser.com
Does BioAge Labs Inc. show high probability of rebound2025 Price Action Summary & AI Driven Price Predictions - newser.com
How to use Fibonacci retracement on BioAge Labs Inc.Trade Ideas & Free Safe Entry Trade Signal Reports - newser.com
BioAge Labs Inc. stock trendline breakdown2025 Volatility Report & AI Powered Market Trend Analysis - newser.com
Is BioAge Labs Inc. stock a buy before product launchesSell Signal & Capital Efficiency Focused Ideas - newser.com
Why BioAge Labs Inc. (Y7G) stock stays undervalued2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com
How BioAge Labs Inc. stock compares to growth peersJuly 2025 Action & Long-Term Growth Stock Strategies - newser.com
What candlestick patterns are forming on BioAge Labs Inc.Long Setup & Consistent Growth Stock Picks - newser.com
Sector ETF performance correlation with BioAge Labs Inc.2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
BioAge Labs Stock: Is a Major Breakout Imminent? - AD HOC NEWS
Is BioAge Labs Inc. (Y7G) stock supported by free cash flowBreakout Watch & Verified Technical Trade Signals - newser.com
Using data models to predict BioAge Labs Inc. stock movementJuly 2025 Big Picture & Reliable Entry Point Trade Alerts - newser.com
Why BioAge Labs Inc. stock could be next big winner2025 Dividend Review & Fast Momentum Stock Entry Tips - newser.com
Analyzing BioAge Labs Inc. with risk reward ratio chartsGap Down & High Conviction Buy Zone Picks - newser.com
Analyzing drawdowns of BioAge Labs Inc. with statistical toolsTake Profit & Precise Swing Trade Entry Alerts - newser.com
Order flow analysis tools used on BioAge Labs Inc.Stop Loss & Safe Entry Momentum Tips - newser.com
BioAge Labs (BIOA) Competitors and Alternatives 2025 - MarketBeat
How strong is BioAge Labs Inc. (Y7G) stock earnings growthJuly 2025 Volume & Trade Opportunity Analysis - newser.com
Obesity Drugmaker Escapes Clinical Trial Securities Suit - Law360
BioAge Labs (NASDAQ:BIOA) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
BioAge Beats IPO Investor Lawsuit Over Weight Loss Trial End (1) - Bloomberg Law News
Automated trading signals detected on BioAge Labs Inc.July 2025 Fed Impact & High Accuracy Investment Signals - newser.com
Can BioAge Labs Inc. stock resist sector downturnsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Bioage Labs Inc (BIOA) 재무 분석
Bioage Labs Inc (BIOA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.60%
0.45%
자본화:
|
볼륨(24시간):